Literature DB >> 8058322

In vitro phosphorylation of caveolin-rich membrane domains: identification of an associated serine kinase activity as a casein kinase II-like enzyme.

M Sargiacomo1, P E Scherer, Z L Tang, J E Casanova, M P Lisanti.   

Abstract

Caveolae are flask-shaped micro-invaginations associated with the plasma membrane of a wide variety of cell types. Caveolin, an integral membrane component of caveolae, was first identified as the major phosphoprotein whose phosphorylation was elevated in v-Src transformed cells. As both v-Src transformation and elevated caveolin phosphorylation were dependent on membrane attachment of v-Src, it has been suggested that caveolin is a critical target in v-Src transformation. Although an increase in tyrosine phosphorylation of caveolin was evident, the increase in caveolin phosphorylation was predominantly on serine residues. In accordance with these in vivo observations, isolated caveolin-rich membrane domains undergo phosphorylation in vitro predominantly on serine and contain an unidentified serine kinase activity. Here, we have identified this serine kinase activity as a casein kinase II-like enzyme, since the phosphorylation of caveolin-rich membrane domains is stimulated and inhibited by known effectors of casein kinase II (poly-L-lysine, endogenous polyamines, and a casein kinase II inhibitor peptide), but is unaffected by modulators of other known kinases. In support of these observations, caveolin contains a consensus sequence for casein kinase II phosphorylation in its cytoplasmic N-terminal domain (Ser-88). A peptide containing this sequence inhibits the in vitro phosphorylation of caveolin-rich membrane domains, while many other peptides derived from the N-terminal domain of caveolin do not affect phosphorylation. Caveolin-rich membrane domains were also a substrate for exogenously added purified casein kinase II, but not casein kinase I. Finally, immunoblotting of these domains with an antibody directed against the alpha and alpha' subunits of casein kinase II reveals two bands with apparent molecular weights consistent with the known molecular weights of the alpha and alpha' subunits of casein kinase II. As casein kinase II appears to play a role in mitogenic signalling events and casein kinase II activators (endogenous polyamines) are required for v-Src transformation, our results may have implications for understanding the mechanism of v-Src oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058322

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

Review 2.  Ecto-protein kinase CK2, the neglected form of CK2.

Authors:  Mathias Montenarh; Claudia Götz
Journal:  Biomed Rep       Date:  2018-02-21

3.  Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells.

Authors:  Katia Fecchi; Daniela Volonte; Michael P Hezel; Kevin Schmeck; Ferruccio Galbiati
Journal:  FASEB J       Date:  2006-02-02       Impact factor: 5.191

4.  Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements.

Authors:  Arvind Dasari; Janine N Bartholomew; Daniela Volonte; Ferruccio Galbiati
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.

Authors:  Daniela Volonte; Aaron J Peoples; Ferruccio Galbiati
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

6.  Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis.

Authors:  Daniel M Greif; David B Sacks; Thomas Michel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-21       Impact factor: 11.205

7.  Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway.

Authors:  Janine N Bartholomew; Daniela Volonte; Ferruccio Galbiati
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

8.  Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.

Authors:  Hyangkyu Lee; David S Park; Babak Razani; Robert G Russell; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  Bovine prion protein as a modulator of protein kinase CK2.

Authors:  F Meggio; A Negro; S Sarno; M Ruzzene; A Bertoli; M C Sorgato; L A Pinna
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

10.  Membrane cholesterol regulates lysosome-plasma membrane fusion events and modulates Trypanosoma cruzi invasion of host cells.

Authors:  Bárbara Hissa; Jacqueline G Duarte; Ludmila F Kelles; Fabio P Santos; Helen L del Puerto; Pedro H Gazzinelli-Guimarães; Ana M de Paula; Ubirajara Agero; Oscar N Mesquita; Cristina Guatimosim; Egler Chiari; Luciana O Andrade
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.